Profusa, Inc. (PFSA) stock
PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
$0.35+0.01 (+1.84%)
Close on Nov 18, 2026Market cap $46.89KP/E –Yield –
Profusa operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Profusa's operating income for the twelve months ending Jun 30, 2026 was -$31.83M. For fiscal 2025 it was -$27.71M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.71M | – |
| FY2024 | Dec 31, 2024 | -$4.50M | – |
| FY2023 | Dec 31, 2023 | -$1.51M | – |
| FY2022 | Dec 31, 2022 | -$1.27M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.55M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.01M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.42M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.08M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.10M | – |
| Q2 FY2024 | Jun 30, 2024 | -$253.13K | – |
| Q1 FY2024 | Mar 31, 2024 | -$470.84K | – |
| Q4 FY2023 | Dec 31, 2023 | -$460.16K | – |
| Q3 FY2023 | Sep 30, 2023 | -$290.10K | – |
| Q2 FY2023 | Jun 30, 2023 | -$314.71K | – |
| Q1 FY2023 | Mar 31, 2023 | -$443.72K | – |
| Q4 FY2022 | Dec 31, 2022 | -$407.01K | – |
| Q3 FY2022 | Sep 30, 2022 | -$404.43K | – |
| Q2 FY2022 | Jun 30, 2022 | -$217.53K | – |
| Q1 FY2022 | Mar 31, 2022 | -$241.60K | – |
See a number that looks wrong?